Skip to content

Cell-free DNA Methylation Markers for Cancer Screening

Cell-free DNA Methylation Markers for Cancer Screening

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03096938
Enrollment
15000
Registered
2017-03-30
Start date
2017-06-01
Completion date
2021-05-01
Last updated
2017-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Screening

Keywords

cell-free DNA, methylation, markers, cancer, screening

Brief summary

The purpose of this study is to evaluate the role of cell-free DNA methylation markers in cancer screening.

Interventions

Cell-free DNA extraction from plasma samples-Bisulfite conversion of cfDNA-Determination of DNA methylation levels by deep sequencing-Sequencing data analysis

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

1. Subject is average risk for development of cancer 2. Subject able and willing to undergo screening test within 90 days of enrollment 3. Subject is 40 to 74 years of age inclusive 4. Subject is able to comprehend, sign, and date the written informed consent document to participate in the study

Exclusion criteria

1. Subject has any condition which, in the opinion of the investigator should preclude participation in the study 2. Subject has a history of cancer 3. Participation in any interventional clinical study within the previous 30 days in which an experimental treatment is administered or might be administered through a randomized assignment of the subject to one or more study groups.

Design outcomes

Primary

MeasureTime frameDescription
sensitivity (true positive rate)2 yearThe proportion of persons with disease who have a positive test (positive test results among persons with disease)
Specificity (true negative rate)2 yearThe proportion of persons without disease who have a negative test (negative test results among persons without disease)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026